Since our founding in 2006, CENTOGENE has been providing data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases.
Kim serves as CENTOGENE’s Chief Executive Officer. She has more than 30 years’ global […]
Miguel Coego Rios is an experienced senior executive with broad expertise in finance […]
Prof. Peter Bauer, M.D., serves as CENTOGENE's Chief Medical and Genomic Officer, where […]
Ian is a globally experienced industry leader with over 25 years of experience in the […]